Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination dietary supplement containing four main active ingredients: - **Folic acid** (vitamin B9), which is essential for DNA synthesis, red blood cell formation, and prevention of certain types of anemia. - **Omega-3 fatty acids**, primarily eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which are polyunsaturated fats important for cardiovascular health, brain function, and anti-inflammatory effects. - **Selenium**, an essential trace mineral that acts as an antioxidant and supports immune function. - **Vitamin D3** (cholecalciferol), which regulates calcium and phosphorus metabolism to maintain bone health and support immune function. The combination is used to help growth, maintain good health, prevent or treat nutritional deficiencies, support cardiovascular health, promote proper brain/nervous system function, enhance immunity, and maintain bone strength. It may be recommended in situations where multiple micronutrient supplementation is needed[1][2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on folic acid + omega-3 fatty acids + selenium + vitamin D3.